Investigational drug may improve stem cell transplantation for multiple myeloma patients (IMAGE)

Washington University School of Medicine

Investigational drug may improve stem cell transplantation for multiple myeloma patients

Caption

Shown are multiple myeloma cells from a patient. An international phase 3 clinical trial led by Washington University School of Medicine in St. Louis has shown that the investigational drug motixafortide — when combined with the standard therapy for mobilizing stem cells — significantly increased the number of stem cells that can be harvested, compared with treatment with the standard agent alone. If approved, the combination with motixafortide potentially would improve stem cell transplantation for multiple myeloma patients.

Credit

MARIANNA RUZINOVA

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.